Study to Evaluate the Efficacy and Safety of Oral Administration With Nemonoxacin and Levofloxacin in Patients With CAP

NCT01529476 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

540

Enrollment

INDUSTRY

Sponsor class

Conditions

Pneumonia

Interventions

DRUG: Levofloxacin
DRUG: Nemonoxacin

Sponsor

TaiGen Biotechnology Co., Ltd.

Collaborators

[object Object]
[object Object]
[object Object]